Opioid “Pay To Play” Investigation Struggling In Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
Senators want to put the hurt on FDA over allegations of pharma companies paying for influence on pain drug approvals, but so far, the elected officials are the ones grimacing.